MODIFIED SINGLE VARIABLE DOMAIN ANTIBODIES WITH REDUCED BINDING TO ANTI-DRUG-ANTIBODIES
The present invention relates to modified proteins and peptides that have reduced ability to bind to pre-existing antibodies. Such modified protein/peptide molecules can comprise C-terminal additions, extensions or tags and/or certain amino acid substitutions. Such modified molecules (e.g. fusions a...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
13.07.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to modified proteins and peptides that have reduced ability to bind to pre-existing antibodies. Such modified protein/peptide molecules can comprise C-terminal additions, extensions or tags and/or certain amino acid substitutions. Such modified molecules (e.g. fusions and conjugates) comprise proteins, peptides, antigen binding molecules, antibodies or antibody fragments such as single variable domains e.g. human immunoglobulin (antibody) single variable domains, and also single variable domains derived from non-human sources such as a llama or camel, e.g. a VHH including a nanobody ¢ (described in e.g. WO 94/04678 and WO 95/04079 inter alia). The invention further relates to uses, formulations, compositions comprising such modified C terminally extended and/or amino acid substituted molecules and also to methods of production and expression of these molecules. |
---|---|
AbstractList | The present invention relates to modified proteins and peptides that have reduced ability to bind to pre-existing antibodies. Such modified protein/peptide molecules can comprise C-terminal additions, extensions or tags and/or certain amino acid substitutions. Such modified molecules (e.g. fusions and conjugates) comprise proteins, peptides, antigen binding molecules, antibodies or antibody fragments such as single variable domains e.g. human immunoglobulin (antibody) single variable domains, and also single variable domains derived from non-human sources such as a llama or camel, e.g. a VHH including a nanobody ¢ (described in e.g. WO 94/04678 and WO 95/04079 inter alia). The invention further relates to uses, formulations, compositions comprising such modified C terminally extended and/or amino acid substituted molecules and also to methods of production and expression of these molecules. |
Author | MORLEY, PETER STEWARD, MICHAEL DE WILDT, RUDOLF M.T ASHMAN, CLAIRE LEWIS, ALAN PETER SANDAL, THOMAS BIRCHLER, MARY HOLLAND, CLAIRE |
Author_xml | – fullname: ASHMAN, CLAIRE – fullname: HOLLAND, CLAIRE – fullname: LEWIS, ALAN PETER – fullname: DE WILDT, RUDOLF M.T – fullname: MORLEY, PETER – fullname: SANDAL, THOMAS – fullname: STEWARD, MICHAEL – fullname: BIRCHLER, MARY |
BookMark | eNrjYmDJy89L5WQI9_V38XTzdHVRCPb0c_dxVQhzDPJ0dAIyXPx9HT39FBz9QjydgGpcgxXCPUM8FIJcXUKdgcqdPP1cgDoUQvzBSnRdgkLddRGKeRhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAkaWFuYWBmaOxMRFKAHfBMis |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | MODIFIZIERTE EINZEL VARIABLE DOMÄNEN ANTIKÖRPER MIT REDUZIERTER BINDUNG AN ANTI-MEDIKAMENTEN-ANTIKÖRPER ANTICORPS MODIFIÉS À DOMAINE VARIABLE UNIQUE PRÉSENTANT UNE DIMINUTION DE LIAISON POUR DES ANTICORPS ANTI-MÉDICAMENT |
ExternalDocumentID | EP2987806A3 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP2987806A33 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:53:31 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP2987806A33 |
Notes | Application Number: EP20150180982 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160713&DB=EPODOC&CC=EP&NR=2987806A3 |
ParticipantIDs | epo_espacenet_EP2987806A3 |
PublicationCentury | 2000 |
PublicationDate | 20160713 |
PublicationDateYYYYMMDD | 2016-07-13 |
PublicationDate_xml | – month: 07 year: 2016 text: 20160713 day: 13 |
PublicationDecade | 2010 |
PublicationYear | 2016 |
RelatedCompanies | GLAXO GROUP LIMITED |
RelatedCompanies_xml | – name: GLAXO GROUP LIMITED |
Score | 3.0339081 |
Snippet | The present invention relates to modified proteins and peptides that have reduced ability to bind to pre-existing antibodies. Such modified protein/peptide... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
Title | MODIFIED SINGLE VARIABLE DOMAIN ANTIBODIES WITH REDUCED BINDING TO ANTI-DRUG-ANTIBODIES |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160713&DB=EPODOC&locale=&CC=EP&NR=2987806A3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LTsMwzBoDATcYIMZLOaDeKtb1fZhQ27RbEG2n0j1uU9t10i7dxIr4fZxoDy5wsxLHSiw5fiS2AZ4tNbcXpqXLWo7SpOlmKWdzu5A7ha1kWYkqWwTcwsgYjLS3qT5twHKXCyPqhH6L4ogoUQXKey3u6_UhiEXF38rNS77EodVrkPaotPWORbU0VaJuzx_GNPYkz0NIipJeF31rq2M46hEccyual9n3xy5PSln_1ijBBZwMkVhVX0KjrFpw5u0ar7XgNNy-dyO4Fb3NFUzCmLKA-ZR8sKj_7pOxkzDHRYDGocMi4kQpc2Nu3pEJSwck4U11EN1lEcUVJI0FikyTUV8-IF8DCfzUG8i4w9meGzN_uD-LegPNalWVt0B027BNJVMyHp_ISzPXtC6aDsU8N6xF2TXb0P6TzN0_c_dwztnKo5mK-gDN-vOrfEQ1XOdPgoE_FAqEbg |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LTsMwzBoDMW4wQIxnDqi3inV9HybUNu0aWNupdI9b1XadtEs3sSJ-nyTagwvcrMSxEkuOH4ltgGdDzs2FbqiiklNpUlS9FLO5WYjdwpSyrKQqmwfcglDzx8rbTJ01YLnLheF1Qr95cUQqUQWV95rf1-tDEAvzv5Wbl3xJh1avXtLHwtY75tXSZAHbfXcU4cgRHIdCQhj3e9S3NrqaJR_Bsc6K8zLLaWKzpJT1b43incPJiBKr6gtolFUbWs6u8VobToPtezcFt6K3uYRpEGHiERejDxIOhi6aWDGxbArgKLBIiKwwIXbEzDs0JYmPYtZUh6LbJMR0BUoijiLieDwQD8hXgDw3cXyR7jDdcyN1R_uzyNfQrFZVeQNINTVTlzIpY_GJvNRzRelR06GY55qxKHt6Bzp_krn9Z-4JWn4SDNMhCd_v4IyxmEU2JfkemvXnV_lAVXKdP3Jm_gBuNIdb |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MODIFIED+SINGLE+VARIABLE+DOMAIN+ANTIBODIES+WITH+REDUCED+BINDING+TO+ANTI-DRUG-ANTIBODIES&rft.inventor=ASHMAN%2C+CLAIRE&rft.inventor=HOLLAND%2C+CLAIRE&rft.inventor=LEWIS%2C+ALAN+PETER&rft.inventor=DE+WILDT%2C+RUDOLF+M.T&rft.inventor=MORLEY%2C+PETER&rft.inventor=SANDAL%2C+THOMAS&rft.inventor=STEWARD%2C+MICHAEL&rft.inventor=BIRCHLER%2C+MARY&rft.date=2016-07-13&rft.externalDBID=A3&rft.externalDocID=EP2987806A3 |